EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets

Farhana Afroz, Suriya Sharmin, Satyajit Roy Rony, Fatema Moni, Md. Hossain Sohrab

Pharmacology & Pharmacy · 2022 · 13 (05) · 129-139

DOI: 10.4236/pp.2022.135010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology & Pharmacy, 2022. Verfasst von Farhana Afroz und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Afroz, F., Sharmin, S., Rony, S. R., Moni, F., & Sohrab, M. H. (2022). Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets. Pharmacology & Pharmacy, 13(05), 129-139. https://doi.org/10.4236/pp.2022.135010

Vancouver

Afroz F, Sharmin S, Rony SR, Moni F, Sohrab MH. Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets. Pharmacology & Pharmacy. 2022;13(05):129-139. doi:10.4236/pp.2022.135010

BibTeX
@article{Afroz2022,
  author = {Afroz, Farhana and Sharmin, Suriya and Rony, Satyajit Roy and Moni, Fatema and Sohrab, Md. Hossain},
  title = {Quality and Pharmaceutical Equivalence Determinations of Commercially Available Amlodipine Besylate Immediate Release Tablets},
  journal = {Pharmacology & Pharmacy},
  year = {2022},
  volume = {13},
  number = {05},
  pages = {129--139},
  doi = {10.4236/pp.2022.135010}
}
Kostenlos starten →